Literature DB >> 33207874

Comparing Machine Learning Models for Aromatase (P450 19A1).

Kimberley M Zorn1, Daniel H Foil1, Thomas R Lane1, Wendy Hillwalker2, David J Feifarek2, Frank Jones2, William D Klaren2, Ashley M Brinkman2, Sean Ekins1.   

Abstract

Aromatase, or cytochrome P450 19A1, catalyzes the aromatization of androgens to estrogens within the body. Changes in the activity of this enzyme can produce hormonal imbalances that can be detrimental to sexual and skeletal development. Inhibition of this enzyme can occur with drugs and natural products as well as environmental chemicals. Therefore, predicting potential endocrine disruption via exogenous chemicals requires that aromatase inhibition be considered in addition to androgen and estrogen pathway interference. Bayesian machine learning methods can be used for prospective prediction from the molecular structure without the need for experimental data. Herein, the generation and evaluation of multiple machine learning models utilizing different sources of aromatase inhibition data are described. These models are applied to two test sets for external validation with molecules relevant to drug discovery from the public domain. In addition, the performance of multiple machine learning algorithms was evaluated by comparing internal five-fold cross-validation statistics of the training data. These methods to predict aromatase inhibition from molecular structure, when used in concert with estrogen and androgen machine learning models, allow for a more holistic assessment of endocrine-disrupting potential of chemicals with limited empirical data and enable the reduction of the use of hazardous substances.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33207874      PMCID: PMC8194505          DOI: 10.1021/acs.est.0c05771

Source DB:  PubMed          Journal:  Environ Sci Technol        ISSN: 0013-936X            Impact factor:   9.028


  59 in total

1.  The ToxCast program for prioritizing toxicity testing of environmental chemicals.

Authors:  David J Dix; Keith A Houck; Matthew T Martin; Ann M Richard; R Woodrow Setzer; Robert J Kavlock
Journal:  Toxicol Sci       Date:  2006-09-08       Impact factor: 4.849

2.  Novel triazole-tetrahydroisoquinoline hybrids as human aromatase inhibitors.

Authors:  Chanamon Chamduang; Ratchanok Pingaew; Veda Prachayasittikul; Supaluk Prachayasittikul; Somsak Ruchirawat; Virapong Prachayasittikul
Journal:  Bioorg Chem       Date:  2019-09-28       Impact factor: 5.275

3.  Assessment of Substrate-Dependent Ligand Interactions at the Organic Cation Transporter OCT2 Using Six Model Substrates.

Authors:  Philip J Sandoval; Kimberley M Zorn; Alex M Clark; Sean Ekins; Stephen H Wright
Journal:  Mol Pharmacol       Date:  2018-06-08       Impact factor: 4.436

Review 4.  Disruption of aromatase homeostasis as the cause of a multiplicity of ailments: A comprehensive review.

Authors:  Seema Patel
Journal:  J Steroid Biochem Mol Biol       Date:  2017-01-18       Impact factor: 4.292

5.  High-throughput screening and Bayesian machine learning for copper-dependent inhibitors of Staphylococcus aureus.

Authors:  Alex G Dalecki; Kimberley M Zorn; Alex M Clark; Sean Ekins; Whitney T Narmore; Nichole Tower; Lynn Rasmussen; Robert Bostwick; Olaf Kutsch; Frank Wolschendorf
Journal:  Metallomics       Date:  2019-03-20       Impact factor: 4.526

6.  Synthesis and docking study of benzimidazole-triazolothiadiazine hybrids as aromatase inhibitors.

Authors:  Ulviye Acar Çevik; Begüm N Sağlık; Derya Osmaniye; Serkan Levent; Betül Kaya Çavuşoğlu; Abdullah B Karaduman; Yusuf Özkay; Zafer A Kaplancıklı
Journal:  Arch Pharm (Weinheim)       Date:  2020-03-11       Impact factor: 3.751

Review 7.  Paradigm shift in toxicity testing and modeling.

Authors:  Hongmao Sun; Menghang Xia; Christopher P Austin; Ruili Huang
Journal:  AAPS J       Date:  2012-04-20       Impact factor: 4.009

8.  Cytochrome P450 fluorometric substrates: identification of isoform-selective probes for rat CYP2D2 and human CYP3A4.

Authors:  David M Stresser; Stephanie D Turner; Andrew P Blanchard; Vaughn P Miller; Charles L Crespi
Journal:  Drug Metab Dispos       Date:  2002-07       Impact factor: 3.922

9.  OPERA models for predicting physicochemical properties and environmental fate endpoints.

Authors:  Kamel Mansouri; Chris M Grulke; Richard S Judson; Antony J Williams
Journal:  J Cheminform       Date:  2018-03-08       Impact factor: 5.514

Review 10.  High Throughput and Computational Repurposing for Neglected Diseases.

Authors:  Helen W Hernandez; Melinda Soeung; Kimberley M Zorn; Norah Ashoura; Melina Mottin; Carolina Horta Andrade; Conor R Caffrey; Jair Lage de Siqueira-Neto; Sean Ekins
Journal:  Pharm Res       Date:  2018-12-17       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.